MedPath

To evaluate the effect of Snehana Karma with Atibala Taila in the management of Kampavata with special reference to Parkinsons Disease.

Completed
Conditions
Diseases of the nervous system. Ayurveda Condition: Parkinsons Disease( Kampavata),
Registration Number
CTRI/2021/04/033268
Lead Sponsor
JS Ayurveda Mahavidyalaya
Brief Summary

Parkinson’s disease is the most common progressive neurodegenerative disorder. This affects the people over the age of 55 years. Clinical features of *Kampa* are similar to the clinical features of Parkinson’s disease. Because *Vata Prakopa* is main pathological factor in *Kampavata* (Parkinson’sdisease), the treatment which pacifies *Vata Dosha* can help in reducingthe signs and symptoms of the disease. *Taila* is considered as the best among all *Vata* pacifying medicaments. *Atibala  Taila* is indicated for *Vata Vyadhi* by *Acharya* *Vagbhatta* in*Astanga* *Hridaya*.

Looking at the progressive nature of the disease, it requires long term treatment. Long term use of the drugs used in conventional medicine for Parkinson’s disease has various side effects. There is need to establish effectiveness of ayurvedic treatment which helps to control signs and symptoms of Parkinson’s disease without having any adverse effects. Hence this study is aimed to establish the effectiveness of *Atibala  Taila* in the management of *Kampavata* i.e. Parkinson’s disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Patients fulfilling diagnostic criteria.
  • Patients between the age group of 40 to 75years.
Exclusion Criteria
  • Patients suffering from severe systemic illnesses like carcinoma, uncontrolled diabetes mellitus, tuberculosis, etc.
  • will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect of Snehana karma with Atibala taila in the patient of Kampavata (Parkinsons disease)Effect of Snehana karma with Atibala taila for 25 days in the patient of Kampavata (Parkinsons disease)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

PD Patel Ayurveda Hospital

🇮🇳

Kheda, GUJARAT, India

PD Patel Ayurveda Hospital
🇮🇳Kheda, GUJARAT, India
Dr Hetal Morazariya
Principal investigator
8866510299
hetalmorzariya@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.